AAAAAA
Results:
1-14
|
Results: 14
Authors:
Abraham, B
Leclercq, C
Bebear, CM
Renaudin, H
Janbon, F
Citation: B. Abraham et al., A case of Ureaplasma urealyticum septic arthritis, MED MAL INF, 31(7-8), 2001, pp. 511-512
Authors:
Hammerschlag, MR
Roblin, PM
Bebear, CM
Citation: Mr. Hammerschlag et al., Activity of telithromycin, a new ketolide antibacterial, against atypical and intracellular respiratory tract pathogens, J ANTIMICRO, 48, 2001, pp. 25-31
Authors:
Pereyre, S
de Barbeyrac, B
Renaudin, H
Poutiers, F
Bebear, C
Bebear, CM
Citation: S. Pereyre et al., In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae, J ANTIMICRO, 47(2), 2001, pp. 240-241
Authors:
Niobe, SN
Bebear, CM
Clerc, M
Pellegrin, JL
Bebear, C
Maugein, J
Citation: Sn. Niobe et al., Disseminated Mycobacterium lentiflavum infection in a human immunodeficiency virus-infected patient, J CLIN MICR, 39(5), 2001, pp. 2030-2032
Authors:
Dhandayuthapani, S
Blaylock, MW
Bebear, CM
Rasmussen, WG
Baseman, JB
Citation: S. Dhandayuthapani et al., Peptide methionine sulfoxide reductase (MsrA) is a virulence determinant in Mycoplasma genitalium, J BACT, 183(19), 2001, pp. 5645-5650
Authors:
Bebear, CM
Renaudin, H
Charron, A
Gruson, D
Lefrancois, M
Bebear, C
Citation: Cm. Bebear et al., In vitro activity of trovafloxacin compared to those of five antimicrobials against mycoplasmas including Mycoplasma hominis and Ureaplasma urealyticum fluoroquinolone-resistant isolates that have been genetically characterized, ANTIM AG CH, 44(9), 2000, pp. 2557-2560
Authors:
Bebear, CM
Renaudin, H
Bryskier, A
Bebear, C
Citation: Cm. Bebear et al., Comparative activities of telithromycin (HMR 3647), levofloxacin, and other antimicrobial agents against human mycoplasmas, ANTIM AG CH, 44(7), 2000, pp. 1980-1982
Authors:
Bebear, CM
Grau, O
Charron, A
Renaudin, H
Gruson, D
Bebear, C
Citation: Cm. Bebear et al., Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected invitro with trovafloxacin, ANTIM AG CH, 44(10), 2000, pp. 2719-2727
Authors:
Schaeverbeke, T
Bebear, CM
Clerc, M
Lequen, L
Bebear, C
Dehais, J
Citation: T. Schaeverbeke et al., What is the role of mycoplasmas in human inflammatory rheumatic disorders?, REV RHUM, 66(1), 1999, pp. 23S-27S
Authors:
Bebear, CM
Schaeverbeke, T
Bebear, C
Citation: Cm. Bebear et al., Characteristics of arthritogenic bacteria - The bacteriologist's point of view, REV RHUM, 66(1), 1999, pp. 57S-59S
Authors:
Gruson, D
Hilbert, G
Portel, L
Boiron, JM
Bebear, CM
Vargas, F
Bebear, C
Reiffers, J
Gbikpi-Benissan, G
Cardinaud, JP
Citation: D. Gruson et al., Severe respiratory failure requiring ICU admission in bone marrow transplant recipients, EUR RESP J, 13(4), 1999, pp. 883-887
Authors:
Bebear, CM
Renaudin, H
Schaeverbeke, T
Leblanc, F
Bebear, C
Citation: Cm. Bebear et al., In-vitro activity of grepafloxacin, a new fluoroquinolone, against mycoplasmas, J ANTIMICRO, 43(5), 1999, pp. 711-714
Authors:
Lelievre, H
Lina, G
Jones, ME
Olive, C
Forey, F
Roussel-Delvallez, M
Nicolas-Chanoine, MH
Bebear, CM
Jarlier, V
Andremont, A
Vandenesch, F
Etienne, J
Citation: H. Lelievre et al., Emergence and spread in French hospitals of methicillin-resistant Staphylococcus aureus with increasing susceptibility to gentamicin and other antibiotics, J CLIN MICR, 37(11), 1999, pp. 3452-3457
Authors:
Bebear, CM
Renaudin, J
Charron, A
Renaudin, H
de Barbeyrac, B
Schaeverbeke, T
Bebear, C
Citation: Cm. Bebear et al., Mutations in the gyrA, parC, and parE genes associated with fluoroquinolone resistance in clinical isolates of Mycoplasma hominis, ANTIM AG CH, 43(4), 1999, pp. 954-956
Risultati:
1-14
|